Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody

Medicine & Life Sciences

• Receptor, Fibroblast Growth Factor, Type 3 100%
• Adenocarcinoma of Lung 69%
• Monoclonal Antibodies 47%
• Mouse Fgf9 protein 31%
• Fibroblast Growth Factor 9 25%
• Ligands 10%
• Neoplasms 6%
• Non-Small Cell Lung Carcinoma 6%
• Lung Neoplasms 5%
• Carcinogenesis 5%
• Epithelial Cells 5%
• Cell Proliferation 4%
• Pathology 4%
• Morbidity 4%
• Mutation 4%
• Antibodies 4%
• Lung 3%
• Growth 3%
• In Vitro Techniques 3%
• Therapeutics 1%

Chemical Compounds

• Mutation 4%
• Ligand 2%